DiaMedica Therapeutics, Inc.

  • Home
  • Our Focus
    • Overview
    • Literature & Publications
  • Pipeline
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • Clinical Trials
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • ReMEDy2 Trial
    • Overview
    • About ReMEDy2
    • Stroke Disease
    • For Physicians
    • Trial Locations
  • About DiaMedica
    • Overview
    • Leadership
    • Careers
    • Contact
  • Investors Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Data
    • Analyst Coverage
    • Financial Reports & SEC Filings
    • Governance
    • Resources

Press Releases

Investors Relations

Investors Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Data
    • Nasdaq Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • Financial Reports & SEC Filings
    • SEC Filings
    • Annual Reports
    • Tax Information (PFIC)
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • Investor Contact
    • FAQ
    • Share Consolidation Instructions
    • Email Alerts
May 08, 2023 8:50am EDT

DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023

Apr 11, 2023 8:41am EDT

DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer

Mar 28, 2023 4:30pm EDT

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results

Mar 20, 2023 4:17pm EDT

DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023

Mar 13, 2023 8:00am EDT

DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

Mar 06, 2023 8:30am EST

DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors

Nov 09, 2022 4:15pm EST

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results

Nov 07, 2022 8:32am EST

DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022

Oct 31, 2022 8:32am EDT

DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference

Oct 26, 2022 4:30pm EDT

DiaMedica Therapeutics Provides Update on ReMEDy2 Trial

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …17
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 DiaMedica Therapeutics, Inc. All Rights Reserved.
Twitter LinkedIn
Privacy Policy Disclaimer Sitemap